K
KNSA
Kiniksa Pharmaceuticals Internat…
48.38
-2.46-4.84%After Hours: 48.39 +0.01 +0.02%19:58 05/29 EDT
OPEN/PREV CLOSE50.72/50.84
TODAY RANGE48.06-50.80
VOL722.26K
MARKET CAP3.72B
52 WEEK RANGE26.27-59.87
AVG VOL (3M)701.02K
% TURNOVER0.94%
TURNOVER--
P/E (TTM)53.36
% RANGE5.04%
EPS(TTM)0.9067
P/E(FORWARD)39.65
P/B6.15
BVPS7.87
DIVIDEND--
P/S5.45
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.15B
SHARES OUTSTANDING76.94M
NEXT EARNINGS07/27-07/31
FREE FLOAT44.46M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
PUBT·05/08 17:30
Kiniksa Pharmaceuticals announces annual shareholder meeting
PUBT·05/08 17:30
Kiniksa publishes 2025 annual report
Simply Wall St·05/06 03:30
Why Kiniksa Pharmaceuticals (KNSA) Is Up 5.4% After Raising 2026 Revenue Guidance And What's Next
Simply Wall St·05/05 01:33
Assessing Kiniksa Pharmaceuticals (KNSA) Valuation After Strong Q1 Results And Raised Revenue Guidance
TipRanks·05/01 21:55
Kiniksa Pharmaceuticals CSO Resigns and Shifts to Advisor
PUBT·05/01 20:33
Kiniksa CEO Sanj K Patel sells shares worth $2.62 million
Simply Wall St·04/30 15:12
Is It Too Late To Consider Kiniksa Pharmaceuticals (KNSA) After Its 91% One-Year Surge?